Huons Co., Ltd. (KOSDAQ:243070)

Market Cap	307.61B -8.1%
Revenue (ttm)	616.80B +4.8%
Net Income	30.69B -3.7%
EPS	2,611.50 -0.4%
Shares Out	11.65M
PE Ratio	10.11
Forward PE	n/a
Dividend	920.00 (3.51%)
Ex-Dividend Date	May 26, 2026

Volume	17,326
Open	26,650
Previous Close	26,200
Day's Range	26,000 - 26,900
52-Week Range	24,350 - 41,500
Beta	0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, anti-coagulant, antiviral, central nervous system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 912
• Stock Exchange: KOSDAQ
• Ticker Symbol: 243070

Financial Performance

In 2025, Huons's revenue was 620.77 billion, an increase of 5.17% compared to the previous year's 590.23 billion. Earnings were 42.66 billion, an increase of 44.84%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 30, 2026

Data Sources Report a data error